Evaluation Of Celecoxib In Combination With Docetaxel In The Treatment Of Advanced Non-Small Cell Lung Cancer Patients Previously Treated With Platinum Based Chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2013
At a glance
- Drugs Celecoxib; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Apr 2010 Actual end date (Feb 2008) added as reported by ClinicalTrials.gov.
- 20 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.